Dec
14
2025
Extended‑release olanzapine may improve adherence to treatments for schizophrenia
As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva’s pursuit of an FDA approval of olanzapine LAI is part of an ongoing attempt to improve...